Observational studyJMIR formative research2026
A Conversational Platform (Okaya) for Multimodal Digital Biomarkers of Fatigue, Cognition, and Mental Health: Feasibility Observational Study.
Observational study in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Conversational Platform (Okaya) for Multimodal Digital Biomarkers of Fatigue, Cognition, and Mental Health: Feasibility Observational Study.JMIR formative research · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Collection of multimodal data (video, audio, and text) can yield digital biomarkers relevant to mental health, fatigue, and cognition. However, the feasibility and signal characteristics in operational populations remain underexplored. Objective: The objectives of this study were to (1) extract an evidence-based library of vision, speech, and language features; (2) assess the feasibility of a fully remote conversational platform (Okaya) for collecting analyzable multimodal data; and (3) conduct preliminary signal checks for depression, fatigue, and cognition. Methods: Participants were recruited from the US Air Force and US Space Force. All participants completed the Okaya check-in, which included a voice conversation with a large language model. A total of 66 visual, acoustic, and text features were extracted from each interaction between the participant and the large language model. For validation purposes, the study also collected measures of depression (Patient Health Questionnaire-9), fatigue (Cancer Fatigue Scale), and cognition (trail making test). We evaluated the feasibility of the platform and correlation between the extracted features and the validated assessments. Results: A total of 8 unique participants contributed with 62 sessions over a period from March 6, 2025, to August 6, 2025. The platform was deemed feasible as 6 of the 8 participants opted to complete more than one session, and the 3 participants who provided feedback reported high overall experience and usability. From the data perspective, preliminary correlations produced significant results for multiple potential digital biomarkers, including (1) pitch (P=.047), volume SD (P=.04), volume slope (P=.04), automated readability index complexity (P=.047), Flesch-Kincaid complexity (P=.04), and Gunning Fog complexity (P=.04) for depression; (2) pitch (P=.009), volume SD (P=.007), volume slope (P=.02), average F2 formant frequency (P=.03), Gunning Fog complexity (P=.049), and eyelid droop (P=.047) for fatigue; and (3) shimmer (P=.03) for cognition. We also observed how features varied over time among participants with multiple sessions. Conclusions: The conversational and artificial intelligence-enabled platform was feasible among an operational sample as a method to collect multimodal data correlated with depression, fatigue, and cognition. These results align with those for previously discovered digital biomarkers of mental health, fatigue, and cognition and inform the development of personalized models for each user while detecting anomalies in a remote monitoring setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.